None listed
Conditions
Brief summary
The purpose of this study is to collect and analyse how lung cancer is managed in Australia, and examine patient outcomes. Who is it for? You may be eligible to join this study if you are aged 18 years or above and have been diagnosed with lung cancer. Study details: Participants in this study will continue to receive routine clinical care, which will not be impacted by involvement in this study. All enrolled patients will have clinical data collected for up to 5 years. Data captured will include presentation of the disease, surgical interventions, prescription of system therapies, and information regarding multidisciplinary management and outcomes of lung cancer in the routine clinical practice setting. This registry will be used to help to describe the current practice patterns so that we can continue to improve the health outcomes of patients diagnosed with lung cancer in Australia.
Interventions
The follow up period is 5 years. No additional tests are required, the project will capture data from the medical record of patients with histological or cytological confirmed lung cancer, or patients with a high clinical suspicion of a lung cancer diagnosis, based on radiological findings. Information regarding the multi-disciplinary management of lung cancer will be collected, including surgery, radiotherapy, systemic therapy and palliative care in the routine clinical practice setting.
Sponsors
The Walter and Eliza Hall Institute of Medical Research
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Histologically or cytologically confirmed diagnosis of lung cancer, or high clinical suspicion of a diagnosis of lung cancer based on radiological findings 2. Patients aged 18 years or above
Exclusion criteria
None
Outcome results
None listed